Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters








Language
Year range
1.
Braz. j. infect. dis ; 6(2): 74-81, Apr. 2002.
Article in English | LILACS, SES-SP | ID: lil-332307

ABSTRACT

Treatment of chronic hepatitis C is still unspecific. However, there is great expectancy concerning the new pegylated interferons. As there has been much controversy about the best parameters to determine whether treatment is effective, we analyzed several criteria currently used for evaluation, including serum alanine aminotransferase (ALT) normalization, viral load reduction and improvement of hepatic histology.


Subject(s)
Humans , Drug Evaluation/methods , Drug Evaluation/standards , Hepatitis C, Chronic/blood , Hepatitis C, Chronic/drug therapy , Antiviral Agents , Interferons , Hepacivirus , Viral Load , Alanine Transaminase , Liver/pathology , Liver/virology , Hepatitis C, Chronic/virology
SELECTION OF CITATIONS
SEARCH DETAIL